Q9Y4K3
Gene name |
TRAF6 (RNF85) |
Protein name |
TNF receptor-associated factor 6 |
Names |
E3 ubiquitin-protein ligase TRAF6, Interleukin-1 signal transducer, RING finger protein 85, RING-type E3 ubiquitin transferase TRAF6 |
Species |
Homo sapiens (Human) |
KEGG Pathway |
hsa:7189 |
EC number |
2.3.2.27: Aminoacyltransferases |
Protein Class |
TNF RECEPTOR ASSOCIATED FACTOR (PTHR10131) |

Descriptions
The Tumor Necrosis Factor (TNF) Receptor Associated Factor (TRAF) class of intracellular signal transducers is responsible for mediating many of the activation events initiated by TNF receptor (TNFR) and Toll-like/Interleukin-1, 17 and 18 receptor (TIR) families. These receptors can, both directly and indirectly, activate TRAF6 via specific binding of proteins containing TRAF Interacting Motif (TIM) peptides to a groove on the carboxyl-terminal MATH domain.
TRAF6 is autoinhibited by an intramolecular interaction between the RING-Zinc (RZ) region and MATH domain. The interaction renders TRAF6 inactive and structurally closed, as well as incapable of auto-ubiquitination. RING-Zinc fingers region and the MATH domain are targets for ubiquitination. TRAF autoubiquitination in trans is a means of sustaining an open conformation active in downstream signaling.
Autoinhibitory domains (AIDs)
Target domain |
70-273 (RZ domain) |
Relief mechanism |
Partner binding |
Assay |
Deletion assay |
Accessory elements
No accessory elements
Autoinhibited structure

Activated structure

14 structures for Q9Y4K3
Entry ID | Method | Resolution | Chain | Position | Source |
---|---|---|---|---|---|
1LB4 | X-ray | 240 A | A | 348-504 | PDB |
1LB5 | X-ray | 240 A | A | 347-504 | PDB |
1LB6 | X-ray | 180 A | A | 347-504 | PDB |
2ECI | NMR | - | A | 50-128 | PDB |
2JMD | NMR | - | A | 67-124 | PDB |
3HCS | X-ray | 220 A | A/B | 50-211 | PDB |
3HCT | X-ray | 210 A | A | 50-159 | PDB |
3HCU | X-ray | 260 A | A/C | 50-159 | PDB |
4Z8M | X-ray | 295 A | A/B | 346-504 | PDB |
5ZUJ | X-ray | 260 A | A | 350-501 | PDB |
6A33 | X-ray | 210 A | A | 350-501 | PDB |
7L3L | X-ray | 280 A | B/D | 52-158 | PDB |
8HZ2 | X-ray | 260 A | A/B | 54-210 | PDB |
AF-Q9Y4K3-F1 | Predicted | AlphaFoldDB |
244 variants for Q9Y4K3
Variant ID(s) | Position | Change | Description | Diseaes Association | Provenance |
---|---|---|---|---|---|
CA5949866 rs547082469 |
11 | G>V | No |
ClinGen 1000Genomes ExAC gnomAD |
|
rs17852887 CA220595446 |
12 | S>F | No |
ClinGen Ensembl |
|
rs748986045 CA5949865 |
12 | S>P | No |
ClinGen ExAC gnomAD |
|
CA380149131 rs1418472079 |
13 | S>R | No |
ClinGen gnomAD |
|
CA5949863 rs769322740 |
17 | S>N | No |
ClinGen ExAC gnomAD |
|
rs1453088768 CA380149077 |
18 | D>E | No |
ClinGen TOPMed |
|
CA380149049 rs1314159296 |
20 | C>Y | No |
ClinGen TOPMed |
|
CA5949861 rs747559755 |
23 | M>V | No |
ClinGen ExAC gnomAD |
|
CA220595424 rs765097739 |
28 | S>R | No |
ClinGen ExAC TOPMed gnomAD |
|
CA5949857 rs370057355 |
29 | A>P | No |
ClinGen ESP ExAC TOPMed gnomAD |
|
CA5949858 rs370057355 |
29 | A>T | No |
ClinGen ESP ExAC TOPMed gnomAD |
|
rs1357823611 CA380148914 |
29 | A>V | No |
ClinGen Ensembl |
|
CA380148903 rs1379813834 |
30 | V>A | No |
ClinGen gnomAD |
|
rs1418393714 CA380148911 |
30 | V>I | No |
ClinGen TOPMed gnomAD |
|
rs1418393714 CA380148909 |
30 | V>L | No |
ClinGen TOPMed gnomAD |
|
CA5949856 rs780618300 |
31 | T>I | No |
ClinGen ExAC gnomAD |
|
CA380148887 rs1421138534 |
32 | K>E | No |
ClinGen gnomAD |
|
CA220595406 rs76605445 |
33 | D>A | No |
ClinGen Ensembl |
|
rs76605445 CA220595404 |
33 | D>G | No |
ClinGen Ensembl |
|
rs758804620 CA5949855 |
35 | S>N | No |
ClinGen ExAC TOPMed gnomAD |
|
rs750708011 CA5949854 |
36 | V>M | No |
ClinGen ExAC gnomAD |
|
CA380148799 rs1259355702 |
38 | G>R | No |
ClinGen gnomAD |
|
CA5949853 rs779230479 |
41 | S>N | No |
ClinGen ExAC gnomAD |
|
rs759328711 CA220595397 |
42 | T>M | No |
ClinGen TOPMed gnomAD |
|
rs753791639 CA5949851 |
43 | G>R | No |
ClinGen ExAC TOPMed gnomAD |
|
CA220595386 rs1031359230 |
44 | N>S | No |
ClinGen TOPMed |
|
CA5949849 rs759449231 |
45 | L>F | No |
ClinGen ExAC gnomAD |
|
rs751488547 CA5949848 |
46 | S>A | No |
ClinGen ExAC |
|
rs1294385877 CA380148698 |
46 | S>F | No |
ClinGen Ensembl |
|
CA380148669 rs1311497253 |
49 | F>L | No |
ClinGen gnomAD |
|
CA380148641 rs1373018587 |
50 | M>I | No |
ClinGen TOPMed |
|
CA5949847 rs766198008 |
50 | M>T | No |
ClinGen ExAC TOPMed gnomAD |
|
rs1590642478 CA380148630 |
51 | E>G | No |
ClinGen Ensembl |
|
rs998647138 CA220595370 |
52 | E>D | No |
ClinGen TOPMed |
|
rs904321355 CA220595367 |
53 | I>N | No |
ClinGen gnomAD |
|
rs772870667 CA5949845 |
58 | V>A | No |
ClinGen ExAC gnomAD |
|
CA380148536 rs1179758607 |
58 | V>I | No |
ClinGen gnomAD |
|
rs1353605695 CA380148488 |
61 | D>G | No |
ClinGen Ensembl |
|
CA380148352 rs1455356924 |
71 | P>A | No |
ClinGen gnomAD |
|
rs199552714 COSM3769288 CA5949843 |
83 | T>M | pancreas [Cosmic] | No |
ClinGen cosmic curated 1000Genomes ExAC |
rs1564968169 CA380148190 |
84 | P>L | No |
ClinGen Ensembl |
|
rs1263751287 CA380148119 |
91 | K>R | No |
ClinGen gnomAD |
|
CA380148101 rs1590642358 |
94 | I>V | No |
ClinGen Ensembl |
|
CA5949839 rs34320471 |
95 | I>L | No |
ClinGen ExAC TOPMed gnomAD |
|
CA220595329 rs1019670034 |
97 | S>* | No |
ClinGen TOPMed |
|
CA380148066 rs1325843053 |
99 | R>K | No |
ClinGen TOPMed |
|
CA380148040 rs1169399583 |
101 | A>S | No |
ClinGen gnomAD |
|
rs368077395 CA5949820 |
109 | N>S | No |
ClinGen ESP ExAC TOPMed gnomAD |
|
rs774914488 CA380147963 |
112 | L>V | No |
ClinGen ExAC gnomAD |
|
rs552722556 CA5949817 |
116 | Q>H | No |
ClinGen 1000Genomes ExAC TOPMed gnomAD |
|
CA5949818 rs771304757 |
116 | Q>K | No |
ClinGen ExAC TOPMed gnomAD |
|
rs1564967420 CA380147914 |
119 | P>R | No |
ClinGen Ensembl |
|
CA5949814 COSM1268460 rs748164490 |
121 | N>S | oesophagus [Cosmic] | No |
ClinGen cosmic curated ExAC gnomAD |
rs945331121 CA220594203 |
125 | R>C | No |
ClinGen gnomAD |
|
rs781247915 CA5949813 |
127 | I>V | No |
ClinGen ExAC gnomAD |
|
rs1255863441 CA380147846 |
129 | S>C | No |
ClinGen gnomAD |
|
rs758390119 CA380147838 |
131 | M>L | No |
ClinGen ExAC gnomAD |
|
CA5949812 rs758390119 |
131 | M>V | No |
ClinGen ExAC gnomAD |
|
CA5949811 rs750341857 |
133 | K>I | No |
ClinGen ExAC gnomAD |
|
CA5949810 rs764984865 |
135 | P>A | No |
ClinGen ExAC gnomAD |
|
rs757037041 CA5949809 |
140 | L>F | No |
ClinGen ExAC gnomAD |
|
CA380147760 rs1448050815 |
141 | H>Q | No |
ClinGen TOPMed |
|
rs915337241 CA220594191 |
144 | E>K | No |
ClinGen Ensembl |
|
CA5949786 rs763790387 |
152 | Q>E | No |
ClinGen ExAC gnomAD |
|
rs763790387 CA380147513 |
152 | Q>K | No |
ClinGen ExAC gnomAD |
|
CA220593597 rs963936751 |
153 | A>T | No |
ClinGen Ensembl |
|
rs1479680091 CA380147502 |
154 | H>Y | No |
ClinGen TOPMed |
|
rs184872313 CA5949784 |
155 | C>S | No |
ClinGen 1000Genomes ExAC gnomAD |
|
rs767175873 CA5949783 |
156 | E>G | No |
ClinGen ExAC gnomAD |
|
CA380147467 rs1293716205 |
158 | A>V | No |
ClinGen gnomAD |
|
rs759073172 CA5949782 |
159 | L>F | No |
ClinGen ExAC TOPMed gnomAD |
|
rs145863131 CA5949781 |
160 | M>T | No |
ClinGen 1000Genomes ESP ExAC TOPMed gnomAD |
|
CA220593563 rs950811873 |
161 | D>N | No |
ClinGen TOPMed gnomAD |
|
rs1186118901 CA380147435 |
163 | P>L | No |
ClinGen TOPMed |
|
CA380147436 rs1564966938 |
163 | P>S | No |
ClinGen Ensembl |
|
CA380147412 rs1429532893 |
166 | Q>R | No |
ClinGen TOPMed |
|
rs374431321 CA5949778 |
167 | R>C | No |
ClinGen ESP ExAC TOPMed gnomAD |
|
rs577802750 CA220593546 |
167 | R>H | No |
ClinGen TOPMed gnomAD |
|
rs75433098 CA220593542 |
169 | F>L | No |
ClinGen Ensembl |
|
CA220593535 rs74830764 |
170 | Q>P | No |
ClinGen Ensembl |
|
rs1394703667 CA380147364 |
173 | H>R | No |
ClinGen gnomAD |
|
rs762066204 CA5949776 |
174 | I>V | No |
ClinGen ExAC gnomAD |
|
CA380147342 rs1324774737 |
176 | I>S | No |
ClinGen gnomAD |
|
rs768746489 CA5949774 |
176 | I>V | No |
ClinGen ExAC TOPMed gnomAD |
|
rs778722636 CA5949772 |
181 | D>A | No |
ClinGen ExAC gnomAD |
|
rs777671341 CA5949769 |
186 | Q>H | No |
ClinGen ExAC gnomAD |
|
CA220593518 rs202213842 |
187 | V>A | No |
ClinGen 1000Genomes |
|
CA220593513 rs1047107972 |
188 | S>Y | No |
ClinGen TOPMed |
|
CA380147247 rs1388994498 |
190 | D>V | No |
ClinGen gnomAD |
|
CA380147242 rs1215343595 |
191 | N>Y | No |
ClinGen gnomAD |
|
rs752427799 CA5949767 |
192 | C>Y | No |
ClinGen ExAC gnomAD |
|
rs780939272 CA5949766 |
194 | A>S | No |
ClinGen ExAC gnomAD |
|
rs780939272 CA380147223 |
194 | A>T | No |
ClinGen ExAC gnomAD |
|
rs754545305 CA5949765 |
194 | A>V | No |
ClinGen ExAC gnomAD |
|
CA380147217 rs1272594739 |
195 | S>P | No |
ClinGen gnomAD |
|
CA5949763 rs765799965 |
196 | M>V | No |
ClinGen ExAC TOPMed gnomAD |
|
rs1466495606 CA380147201 |
197 | A>E | No |
ClinGen gnomAD |
|
rs763566105 CA5949762 |
197 | A>P | No |
ClinGen ExAC TOPMed gnomAD |
|
rs763566105 CA380147203 |
197 | A>S | No |
ClinGen ExAC TOPMed gnomAD |
|
rs370394325 CA5949747 |
203 | I>M | No |
ClinGen ESP ExAC TOPMed gnomAD |
|
CA220592444 rs146832696 |
203 | I>N | No |
ClinGen ESP ExAC TOPMed gnomAD |
|
CA5949748 rs146832696 |
203 | I>T | No |
ClinGen ESP ExAC TOPMed gnomAD |
|
rs1005252014 CA220592445 |
203 | I>V | No |
ClinGen gnomAD |
|
rs145105758 CA5949746 |
206 | Q>R | No |
ClinGen ESP ExAC TOPMed gnomAD |
|
CA380146965 rs1434629204 |
210 | L>S | No |
ClinGen gnomAD |
|
CA380146949 rs1175565773 |
211 | A>V | No |
ClinGen gnomAD |
|
rs148861693 COSM926727 CA5949744 |
212 | N>S | endometrium [Cosmic] | No |
ClinGen cosmic curated ESP ExAC TOPMed gnomAD |
COSM1507898 rs765675724 CA5949742 |
219 | N>S | lung [Cosmic] | No |
ClinGen cosmic curated ExAC TOPMed gnomAD |
CA380146839 rs1325739918 |
221 | I>T | No |
ClinGen gnomAD |
|
rs200882261 CA5949741 |
221 | I>V | No |
ClinGen 1000Genomes ESP ExAC TOPMed gnomAD |
|
CA380146825 rs1210133922 |
223 | I>V | No |
ClinGen gnomAD |
|
rs754269736 CA5949740 |
225 | E>K | No |
ClinGen ExAC TOPMed gnomAD |
|
rs754269736 CA380146807 |
225 | E>Q | No |
ClinGen ExAC TOPMed gnomAD |
|
CA5949720 rs756392662 |
227 | M>I | No |
ClinGen ExAC gnomAD |
|
rs752986438 CA5949719 |
228 | P>S | No |
ClinGen ExAC gnomAD |
|
rs767573599 CA5949718 |
233 | L>V | No |
ClinGen ExAC TOPMed gnomAD |
|
CA380146043 rs1291857212 |
234 | D>V | No |
ClinGen gnomAD |
|
CA5949717 rs759661560 |
235 | C>F | No |
ClinGen ExAC gnomAD |
|
rs1356662734 CA380146017 |
236 | P>R | No |
ClinGen gnomAD |
|
CA380146005 rs1365384154 |
238 | A>T | No |
ClinGen TOPMed |
|
rs1295724464 CA380145981 |
240 | I>V | No |
ClinGen gnomAD |
|
rs774636689 CA5949716 |
241 | P>L | No |
ClinGen ExAC TOPMed gnomAD |
|
rs377030527 CA5949715 |
245 | S>R | No |
ClinGen ESP ExAC TOPMed gnomAD |
|
CA5949714 rs376945338 |
247 | F>S | No |
ClinGen ESP ExAC gnomAD |
|
rs1477427444 CA380145893 |
248 | G>D | No |
ClinGen gnomAD |
|
CA5949713 rs776672755 |
248 | G>R | No |
ClinGen ExAC |
|
CA380145860 rs1455564718 |
251 | E>K | No |
ClinGen gnomAD |
|
CA380145850 rs1305709407 |
252 | K>E | No |
ClinGen TOPMed |
|
rs1375802941 CA380145844 |
252 | K>R | No |
ClinGen TOPMed gnomAD |
|
rs775208286 CA5949686 |
253 | M>I | No |
ClinGen ExAC gnomAD |
|
rs760658124 CA5949687 |
253 | M>V | No |
ClinGen ExAC gnomAD |
|
rs1255316683 CA380145633 |
259 | A>S | No |
ClinGen gnomAD |
|
CA380145624 rs771879519 |
260 | R>C | No |
ClinGen ExAC TOPMed gnomAD |
|
CA5949685 rs771879519 |
260 | R>S | No |
ClinGen ExAC TOPMed gnomAD |
|
rs759228997 CA5949684 |
262 | L>Q | No |
ClinGen ExAC gnomAD |
|
rs1590634108 CA380145522 |
269 | H>N | No |
ClinGen Ensembl |
|
CA5949683 rs773951368 |
270 | M>I | No |
ClinGen ExAC gnomAD |
|
CA220590001 rs963487647 |
273 | L>F | No |
ClinGen TOPMed |
|
CA380145413 rs1441975568 |
278 | H>D | No |
ClinGen gnomAD |
|
CA380145409 rs1441975568 |
278 | H>N | No |
ClinGen gnomAD |
|
CA220589990 rs55840758 |
279 | S>N | No |
ClinGen Ensembl |
|
rs1397134360 CA380145346 |
282 | V>D | No |
ClinGen gnomAD |
|
CA5949680 rs376933557 |
282 | V>F | No |
ClinGen ESP ExAC TOPMed gnomAD |
|
CA5949679 rs376933557 |
282 | V>I | No |
ClinGen ESP ExAC TOPMed gnomAD |
|
CA5949678 rs748672638 |
283 | I>M | No |
ClinGen ExAC TOPMed gnomAD |
|
rs1169635412 CA380145329 |
283 | I>T | No |
ClinGen gnomAD |
|
CA380145305 rs1173673453 |
284 | P>R | No |
ClinGen gnomAD |
|
CA5949677 rs781456089 |
284 | P>T | No |
ClinGen ExAC gnomAD |
|
rs1158440319 CA380145290 |
285 | D>G | No |
ClinGen TOPMed |
|
CA5949675 rs751855450 |
285 | D>N | No |
ClinGen ExAC gnomAD |
|
CA5949674 rs147645716 |
286 | S>P | No |
ClinGen ESP ExAC TOPMed gnomAD |
|
CA5949673 rs758560289 |
287 | G>E | No |
ClinGen ExAC gnomAD |
|
rs900697253 CA220589921 |
288 | Y>C | No |
ClinGen TOPMed |
|
CA5949672 rs750597806 |
288 | Y>H | No |
ClinGen ExAC gnomAD |
|
rs1207985971 COSM3700062 CA5949670 |
289 | I>V | liver [Cosmic] | No |
ClinGen cosmic curated gnomAD |
CA380145197 COSM1507899 rs1279744976 |
292 | V>F | lung [Cosmic] | No |
ClinGen cosmic curated gnomAD |
CA5949668 rs78639425 |
293 | R>Q | No |
ClinGen ExAC TOPMed gnomAD |
|
CA220589887 rs776312804 |
293 | R>W | No |
ClinGen Ensembl |
|
CA380145157 rs1277936375 |
294 | N>H | No |
ClinGen gnomAD |
|
CA380145081 rs1165511778 |
298 | T>S | No |
ClinGen Ensembl |
|
CA5949666 rs767244798 |
299 | I>V | No |
ClinGen ExAC gnomAD |
|
rs759276140 CA5949665 |
300 | H>Q | No |
ClinGen ExAC gnomAD |
|
CA380145025 rs1412886563 |
301 | Q>R | No |
ClinGen gnomAD |
|
CA5949663 rs770500483 |
314 | R>W | No |
ClinGen ExAC gnomAD |
|
rs762588981 CA5949662 |
321 | E>Q | No |
ClinGen ExAC gnomAD |
|
rs1157696222 CA380144719 |
324 | S>N | No |
ClinGen TOPMed gnomAD |
|
rs1157696222 CA380144717 |
324 | S>T | No |
ClinGen TOPMed gnomAD |
|
rs145275891 CA5949660 |
325 | M>I | No |
ClinGen ESP ExAC TOPMed gnomAD |
|
rs145275891 CA5949659 |
325 | M>I | No |
ClinGen ESP ExAC TOPMed gnomAD |
|
rs1470296867 CA380144709 |
325 | M>V | No |
ClinGen TOPMed gnomAD |
|
rs1184735808 CA380144691 |
326 | Y>C | No |
ClinGen gnomAD |
|
rs780561325 COSM1230215 CA5949655 |
332 | R>Q | large_intestine [Cosmic] | No |
ClinGen cosmic curated ExAC TOPMed gnomAD |
CA5949654 rs535909443 |
333 | T>N | No |
ClinGen ExAC gnomAD |
|
CA220589778 rs535909443 |
333 | T>S | No |
ClinGen ExAC gnomAD |
|
CA5949652 rs778902552 |
334 | I>V | No |
ClinGen ExAC gnomAD |
|
rs1351619329 COSM285912 CA380144598 |
335 | R>* | large_intestine endometrium [Cosmic] | No |
ClinGen cosmic curated gnomAD |
rs1351619329 CA380144600 |
335 | R>G | No |
ClinGen gnomAD |
|
CA380144574 rs1231164368 |
337 | L>F | No |
ClinGen gnomAD |
|
CA380144565 rs1354747764 |
338 | E>K | No |
ClinGen TOPMed gnomAD |
|
CA380144536 rs1293903033 |
340 | K>E | No |
ClinGen TOPMed gnomAD |
|
CA5949650 rs752595856 |
341 | V>I | No |
ClinGen ExAC gnomAD |
|
rs1342978071 CA380144511 |
342 | A>P | No |
ClinGen gnomAD |
|
rs1400964751 CA380144479 |
344 | I>M | No |
ClinGen TOPMed gnomAD |
|
CA380144485 rs1440580411 |
344 | I>N | No |
ClinGen TOPMed |
|
rs147417401 CA5949649 |
344 | I>V | No |
ClinGen ESP ExAC TOPMed gnomAD |
|
CA5949647 rs751422527 |
350 | N>D | No |
ClinGen ExAC gnomAD |
|
CA5949646 rs766148455 |
350 | N>S | No |
ClinGen ExAC TOPMed gnomAD |
|
CA5949645 rs762641979 |
353 | Y>S | No |
ClinGen ExAC gnomAD |
|
CA380144294 rs1286505713 |
358 | G>V | No |
ClinGen gnomAD |
|
rs761330797 CA5949642 |
359 | N>S | No |
ClinGen ExAC gnomAD |
|
CA5949641 rs376266610 |
361 | G>R | No |
ClinGen ExAC TOPMed |
|
rs747509379 CA5949638 |
362 | M>I | No |
ClinGen ExAC TOPMed gnomAD |
|
rs148751232 CA5949639 |
362 | M>T | No |
ClinGen ESP ExAC TOPMed gnomAD |
|
CA380144233 rs1447813072 |
363 | H>Y | No |
ClinGen gnomAD |
|
rs776049763 CA5949637 |
364 | L>W | No |
ClinGen ExAC gnomAD |
|
CA5949635 rs746111041 COSM428952 |
369 | E>K | kidney breast [Cosmic] | No |
ClinGen cosmic curated ExAC gnomAD |
CA380143990 rs1401987236 |
381 | Y>H | No |
ClinGen TOPMed |
|
CA380143858 rs1564964638 |
391 | M>L | No |
ClinGen Ensembl |
|
CA380143783 rs1183306064 |
396 | Q>P | No |
ClinGen Ensembl |
|
rs1394252847 CA380143722 |
401 | Q>R | No |
ClinGen TOPMed gnomAD |
|
rs548543739 CA5949628 |
402 | R>C | No |
ClinGen 1000Genomes ExAC gnomAD |
|
rs199830912 CA5949627 |
402 | R>H | No |
ClinGen 1000Genomes ExAC TOPMed gnomAD |
|
rs1417916854 CA380143648 |
406 | Y>C | No |
ClinGen gnomAD |
|
rs1299539710 CA380143630 |
407 | I>M | No |
ClinGen gnomAD |
|
rs1475820971 CA380143520 |
417 | E>K | No |
ClinGen TOPMed gnomAD |
|
rs1475820971 CA380143518 |
417 | E>Q | No |
ClinGen TOPMed gnomAD |
|
rs916447705 CA380143473 |
420 | S>N | No |
ClinGen TOPMed gnomAD |
|
rs761368102 CA5949624 |
420 | S>R | No |
ClinGen ExAC TOPMed gnomAD |
|
rs916447705 CA220589614 |
420 | S>T | No |
ClinGen TOPMed gnomAD |
|
CA380143455 rs1413660417 |
422 | L>I | No |
ClinGen TOPMed |
|
rs1223436642 CA380143447 |
422 | L>P | No |
ClinGen gnomAD |
|
CA380143437 rs1564964595 |
423 | P>S | No |
ClinGen Ensembl |
|
rs1162144803 CA380143380 |
427 | Q>L | No |
ClinGen TOPMed |
|
CA5949623 rs776263136 |
430 | I>V | No |
ClinGen ExAC gnomAD |
|
CA380143339 rs1343753001 |
431 | R>C | No |
ClinGen gnomAD |
|
rs200661146 CA5949622 |
434 | I>V | No |
ClinGen 1000Genomes ExAC gnomAD |
|
rs749812433 CA220589592 |
439 | E>A | No |
ClinGen Ensembl |
|
rs1437970764 CA380143240 |
439 | E>Q | No |
ClinGen Ensembl |
|
rs776102924 COSM1507900 CA5949620 |
442 | V>L | lung [Cosmic] | No |
ClinGen cosmic curated ExAC gnomAD |
CA380143186 rs1327006408 |
443 | R>K | No |
ClinGen gnomAD |
|
CA380143101 rs1353116587 |
449 | I>V | No |
ClinGen gnomAD |
|
CA5949618 rs746183280 |
452 | A>T | No |
ClinGen ExAC gnomAD |
|
CA380143032 rs1410994328 |
454 | P>A | No |
ClinGen gnomAD |
|
CA5949617 rs774438696 |
455 | E>K | No |
ClinGen ExAC gnomAD |
|
CA5949615 rs749457723 |
461 | R>Q | No |
ClinGen ExAC gnomAD |
|
CA220589540 rs773499691 |
463 | T>A | No |
ClinGen gnomAD |
|
CA220589535 rs942112506 |
463 | T>I | No |
ClinGen TOPMed |
|
CA380142906 rs1479576702 |
465 | P>A | No |
ClinGen gnomAD |
|
rs1378303413 COSM73056 CA380142894 |
466 | R>W | ovary [Cosmic] | No |
ClinGen cosmic curated TOPMed |
rs746978261 CA5949612 |
482 | L>I | No |
ClinGen ExAC TOPMed gnomAD |
|
rs779910368 CA380141698 |
492 | T>I | No |
ClinGen ExAC gnomAD |
|
rs779910368 CA5949611 |
492 | T>K | No |
ClinGen ExAC gnomAD |
|
CA380141651 rs1249361694 |
496 | R>H | No |
ClinGen Ensembl |
|
CA5949607 rs756987677 |
502 | R>H | No |
ClinGen ExAC TOPMed gnomAD |
|
CA380141526 rs1211229906 |
505 | M>I | No |
ClinGen TOPMed |
|
rs753514303 CA5949606 |
505 | M>V | No |
ClinGen ExAC gnomAD |
|
CA380141515 rs1434112138 |
506 | G>D | No |
ClinGen gnomAD |
|
rs58304191 CA5949605 |
507 | S>C | No |
ClinGen 1000Genomes ExAC TOPMed gnomAD |
|
CA220589483 rs950725856 |
518 | T>S | No |
ClinGen TOPMed gnomAD |
|
CA5949602 rs138175660 |
519 | D>G | No |
ClinGen ESP ExAC TOPMed gnomAD |
|
CA5949603 rs372550520 |
519 | D>N | No |
ClinGen ESP ExAC TOPMed gnomAD |
|
rs1030321317 CA220589441 |
521 | G>R | No |
ClinGen TOPMed |
|
CA5949601 rs759952168 |
522 | V>L | No |
ClinGen ExAC TOPMed gnomAD |
|
CA5949600 rs774832063 |
523 | V>Q | No |
ClinGen ExAC gnomAD |
No associated diseases with Q9Y4K3
8 regional properties for Q9Y4K3
Type | Name | Position | InterPro Accession |
---|---|---|---|
domain | Zinc finger, TRAF-type | 151 - 192 | IPR001293-1 |
domain | Zinc finger, TRAF-type | 204 - 261 | IPR001293-2 |
domain | Zinc finger, RING-type | 70 - 109 | IPR001841 |
domain | MATH/TRAF domain | 350 - 499 | IPR002083 |
conserved_site | Zinc finger, RING-type, conserved site | 85 - 94 | IPR017907 |
domain | TNF receptor-associated factor 6, C3HC3D-type RING zinc finger | 67 - 124 | IPR027139 |
domain | TNF receptor-associated factor 6, MATH domain | 351 - 500 | IPR037309 |
domain | TNF receptor-associated factor 6, zinc finger 2 | 157 - 183 | IPR041310 |
Functions
Description | ||
---|---|---|
EC Number | 2.3.2.27 | Aminoacyltransferases |
Subcellular Localization |
|
|
PANTHER Family | PTHR10131 | TNF RECEPTOR ASSOCIATED FACTOR |
PANTHER Subfamily | PTHR10131:SF131 | TNF RECEPTOR-ASSOCIATED FACTOR 6 |
PANTHER Protein Class | scaffold/adaptor protein | |
PANTHER Pathway Category |
CCKR signaling map TRAF6 p38 MAPK pathway TRAF6 Toll receptor signaling pathway TRAF6 |
11 GO annotations of cellular component
Name | Definition |
---|---|
CD40 receptor complex | A protein complex that contains at least CD40 (a cell surface receptor of the tumour necrosis factor receptor (TNFR) superfamily), and other signaling molecules. |
cell cortex | The region of a cell that lies just beneath the plasma membrane and often, but not always, contains a network of actin filaments and associated proteins. |
cytoplasm | The contents of a cell excluding the plasma membrane and nucleus, but including other subcellular structures. |
cytoplasmic side of plasma membrane | The leaflet the plasma membrane that faces the cytoplasm and any proteins embedded or anchored in it or attached to its surface. |
cytosol | The part of the cytoplasm that does not contain organelles but which does contain other particulate matter, such as protein complexes. |
endosome membrane | The lipid bilayer surrounding an endosome. |
lipid droplet | An intracellular non-membrane-bounded organelle comprising a matrix of coalesced lipids surrounded by a phospholipid monolayer. May include associated proteins. |
nucleus | A membrane-bounded organelle of eukaryotic cells in which chromosomes are housed and replicated. In most cells, the nucleus contains all of the cell's chromosomes except the organellar chromosomes, and is the site of RNA synthesis and processing. In some species, or in specialized cell types, RNA metabolism or DNA replication may be absent. |
perinuclear region of cytoplasm | Cytoplasm situated near, or occurring around, the nucleus. |
plasma membrane | The membrane surrounding a cell that separates the cell from its external environment. It consists of a phospholipid bilayer and associated proteins. |
protein-containing complex | A stable assembly of two or more macromolecules, i.e. proteins, nucleic acids, carbohydrates or lipids, in which at least one component is a protein and the constituent parts function together. |
14 GO annotations of molecular function
Name | Definition |
---|---|
histone deacetylase binding | Binding to histone deacetylase. |
identical protein binding | Binding to an identical protein or proteins. |
mitogen-activated protein kinase kinase kinase binding | Binding to a mitogen-activated protein kinase kinase kinase, a protein that can phosphorylate a MAP kinase kinase. |
protein kinase B binding | Binding to protein kinase B, an intracellular kinase that is important in regulating glucose metabolism. |
protein kinase binding | Binding to a protein kinase, any enzyme that catalyzes the transfer of a phosphate group, usually from ATP, to a protein substrate. |
protein N-terminus binding | Binding to a protein N-terminus, the end of any peptide chain at which the 2-amino (or 2-imino) function of a constituent amino acid is not attached in peptide linkage to another amino-acid residue. |
thioesterase binding | Binding to a thioesterase. |
tumor necrosis factor receptor binding | Binding to a tumor necrosis factor receptor. |
tumor necrosis factor receptor superfamily binding | Binding to a member of the tumor necrosis factor receptor superfamily. |
ubiquitin conjugating enzyme binding | Binding to a ubiquitin conjugating enzyme, any of the E2 proteins. |
ubiquitin protein ligase activity | Catalysis of the transfer of ubiquitin to a substrate protein via the reaction X-ubiquitin + S -> X + S-ubiquitin, where X is either an E2 or E3 enzyme, the X-ubiquitin linkage is a thioester bond, and the S-ubiquitin linkage is an amide bond: an isopeptide bond between the C-terminal glycine of ubiquitin and the epsilon-amino group of lysine residues in the substrate or, in the linear extension of ubiquitin chains, a peptide bond the between the C-terminal glycine and N-terminal methionine of ubiquitin residues. |
ubiquitin protein ligase binding | Binding to a ubiquitin protein ligase enzyme, any of the E3 proteins. |
ubiquitin-protein transferase activity | Catalysis of the transfer of ubiquitin from one protein to another via the reaction X-Ub + Y --> Y-Ub + X, where both X-Ub and Y-Ub are covalent linkages. |
zinc ion binding | Binding to a zinc ion (Zn). |
50 GO annotations of biological process
Name | Definition |
---|---|
activation of NF-kappaB-inducing kinase activity | The stimulation of the activity of NF-kappaB-inducing kinase through phosphorylation at specific residues. |
activation of protein kinase activity | Any process that initiates the activity of an inactive protein kinase. |
antigen processing and presentation of exogenous peptide antigen via MHC class II | The process in which an antigen-presenting cell expresses a peptide antigen of exogenous origin on its cell surface in association with an MHC class II protein complex. The peptide antigen is typically, but not always, processed from a whole protein. |
bone resorption | The process in which specialized cells known as osteoclasts degrade the organic and inorganic portions of bone, and endocytose and transport the degradation products. |
cell development | The process whose specific outcome is the progression of the cell over time, from its formation to the mature structure. Cell development does not include the steps involved in committing a cell to a specific fate. |
cellular response to cytokine stimulus | Any process that results in a change in state or activity of a cell (in terms of movement, secretion, enzyme production, gene expression, etc.) as a result of a cytokine stimulus. |
cellular response to DNA damage stimulus | Any process that results in a change in state or activity of a cell (in terms of movement, secretion, enzyme production, gene expression, etc.) as a result of a stimulus indicating damage to its DNA from environmental insults or errors during metabolism. |
cellular response to lipopolysaccharide | Any process that results in a change in state or activity of a cell (in terms of movement, secretion, enzyme production, gene expression, etc.) as a result of a lipopolysaccharide stimulus; lipopolysaccharide is a major component of the cell wall of gram-negative bacteria. |
cytoplasmic pattern recognition receptor signaling pathway | The series of molecular signals initiated by a ligand binding to a cytoplasmic pattern recognition receptor (PRR). PRRs bind pathogen-associated molecular pattern (PAMPs), structures conserved among microbial species. |
Fc-epsilon receptor signaling pathway | The series of molecular signals initiated by the binding of the Fc portion of immunoglobulin E (IgE) to an Fc-epsilon receptor on the surface of a target cell, and ending with the regulation of a downstream cellular process, e.g. transcription. The Fc portion of an immunoglobulin is its C-terminal constant region. |
I-kappaB kinase/NF-kappaB signaling | The process in which a signal is passed on to downstream components within the cell through the I-kappaB-kinase (IKK)-dependent activation of NF-kappaB. The cascade begins with activation of a trimeric IKK complex (consisting of catalytic kinase subunits IKKalpha and/or IKKbeta, and the regulatory scaffold protein NEMO) and ends with the regulation of transcription of target genes by NF-kappaB. In a resting state, NF-kappaB dimers are bound to I-kappaB proteins, sequestering NF-kappaB in the cytoplasm. Phosphorylation of I-kappaB targets I-kappaB for ubiquitination and proteasomal degradation, thus releasing the NF-kappaB dimers, which can translocate to the nucleus to bind DNA and regulate transcription. |
in utero embryonic development | The process whose specific outcome is the progression of the embryo in the uterus over time, from formation of the zygote in the oviduct, to birth. An example of this process is found in Mus musculus. |
interleukin-1-mediated signaling pathway | The series of molecular signals initiated by interleukin-1 binding to its receptor on the surface of a target cell, and ending with the regulation of a downstream cellular process, e.g. transcription. |
interleukin-17-mediated signaling pathway | The series of molecular signals initiated by interleukin-17 binding to its receptor on the surface of a target cell, and ending with the regulation of a downstream cellular process, e.g. transcription. |
MyD88-dependent toll-like receptor signaling pathway | A toll-like receptor signaling pathway in which the MyD88 adaptor molecule mediates transduction of the signal. Toll-like receptors directly bind pattern motifs from a variety of microbial sources to initiate an innate immune response. |
myeloid dendritic cell differentiation | The process in which a monocyte acquires the specialized features of a dendritic cell, an immunocompetent cell of the lymphoid and hemopoietic systems and skin. |
negative regulation of transcription by RNA polymerase II | Any process that stops, prevents, or reduces the frequency, rate or extent of transcription mediated by RNA polymerase II. |
negative regulation of transcription, DNA-templated | Any process that stops, prevents, or reduces the frequency, rate or extent of cellular DNA-templated transcription. |
neural tube closure | The last step in the formation of the neural tube, where the paired neural folds are brought together and fuse at the dorsal midline. |
odontogenesis of dentin-containing tooth | The process whose specific outcome is the progression of a dentin-containing tooth over time, from its formation to the mature structure. A dentin-containing tooth is a hard, bony organ borne on the jaw or other bone of a vertebrate, and is composed mainly of dentin, a dense calcified substance, covered by a layer of enamel. |
ossification | The formation of bone or of a bony substance, or the conversion of fibrous tissue or of cartilage into bone or a bony substance. |
osteoclast differentiation | The process in which a relatively unspecialized monocyte acquires the specialized features of an osteoclast. An osteoclast is a specialized phagocytic cell associated with the absorption and removal of the mineralized matrix of bone tissue. |
positive regulation of DNA-binding transcription factor activity | Any process that activates or increases the frequency, rate or extent of activity of a transcription factor, any factor involved in the initiation or regulation of transcription. |
positive regulation of I-kappaB kinase/NF-kappaB signaling | Any process that activates or increases the frequency, rate or extent of I-kappaB kinase/NF-kappaB signaling. |
positive regulation of interleukin-12 production | Any process that activates or increases the frequency, rate, or extent of interleukin-12 production. |
positive regulation of interleukin-2 production | Any process that activates or increases the frequency, rate, or extent of interleukin-2 production. |
positive regulation of interleukin-6 production | Any process that activates or increases the frequency, rate, or extent of interleukin-6 production. |
positive regulation of JNK cascade | Any process that activates or increases the frequency, rate or extent of signal transduction mediated by the JNK cascade. |
positive regulation of JUN kinase activity | Any process that activates or increases the frequency, rate or extent of JUN kinase activity. |
positive regulation of leukocyte adhesion to vascular endothelial cell | Any process that activates or increases the frequency, rate or extent of leukocyte adhesion to vascular endothelial cell. |
positive regulation of lipopolysaccharide-mediated signaling pathway | Any process that activates or increases the frequency, rate or extent of signaling in response to detection of lipopolysaccharide. |
positive regulation of NF-kappaB transcription factor activity | Any process that activates or increases the frequency, rate or extent of activity of the transcription factor NF-kappaB. |
positive regulation of NIK/NF-kappaB signaling | Any process that activates or increases the frequency, rate or extent of NIK/NF-kappaB signaling. |
positive regulation of osteoclast differentiation | Any process that activates or increases the frequency, rate or extent of osteoclast differentiation. |
positive regulation of protein ubiquitination | Any process that activates or increases the frequency, rate or extent of the addition of ubiquitin groups to a protein. |
positive regulation of T cell cytokine production | Any process that activates or increases the frequency, rate, or extent of T cell cytokine production. |
positive regulation of T cell proliferation | Any process that activates or increases the rate or extent of T cell proliferation. |
positive regulation of transcription by RNA polymerase II | Any process that activates or increases the frequency, rate or extent of transcription from an RNA polymerase II promoter. |
positive regulation of transcription regulatory region DNA binding | Any process that activates or increases the frequency, rate or extent of transcription regulatory region DNA binding. |
protein autoubiquitination | The ubiquitination by a protein of one or more of its own amino acid residues, or residues on an identical protein. Ubiquitination occurs on the lysine residue by formation of an isopeptide crosslink. |
protein K63-linked ubiquitination | A protein ubiquitination process in which a polymer of ubiquitin, formed by linkages between lysine residues at position 63 of the ubiquitin monomers, is added to a protein. K63-linked ubiquitination does not target the substrate protein for degradation, but is involved in several pathways, notably as a signal to promote error-free DNA postreplication repair. |
protein polyubiquitination | Addition of multiple ubiquitin groups to a protein, forming a ubiquitin chain. |
regulation of apoptotic process | Any process that modulates the occurrence or rate of cell death by apoptotic process. |
regulation of I-kappaB kinase/NF-kappaB signaling | Any process that modulates I-kappaB kinase/NF-kappaB signaling. |
regulation of immunoglobulin production | Any process that modulates the frequency, rate, or extent of immunoglobulin production. |
response to interleukin-1 | Any process that results in a change in state or activity of a cell or an organism (in terms of movement, secretion, enzyme production, gene expression, etc.) as a result of an interleukin-1 stimulus. |
stimulatory C-type lectin receptor signaling pathway | The series of molecular signals initiated by the binding of C-type lectin to its receptor on the surface of a target cell, and resulting in cellular activation. |
T cell receptor signaling pathway | The series of molecular signals initiated by the cross-linking of an antigen receptor on a T cell. |
T-helper 1 type immune response | An immune response which is associated with resistance to intracellular bacteria, fungi, and protozoa, and pathological conditions such as arthritis, and which is typically orchestrated by the production of particular cytokines by T-helper 1 cells, most notably interferon-gamma, IL-2, and lymphotoxin. |
tumor necrosis factor-mediated signaling pathway | The series of molecular signals initiated by tumor necrosis factor binding to its receptor on the surface of a cell, and ending with the regulation of a downstream cellular process, e.g. transcription. |
7 homologous proteins in AiPD
UniProt AC | Gene Name | Protein Name | Species | Evidence Code |
---|---|---|---|---|
Q3ZCC3 | TRAF6 | TNF receptor-associated factor 6 | Bos taurus (Bovine) | SS |
P70196 | Traf6 | TNF receptor-associated factor 6 | Mus musculus (Mouse) | SS |
A7XUJ6 | TRAF6 | TNF receptor-associated factor 6 | Sus scrofa (Pig) | SS |
B5DF45 | Traf6 | TNF receptor-associated factor 6 | Rattus norvegicus (Rat) | SS |
B6CJY5 | TRAF6 | TNF receptor-associated factor 6 | Macaca mulatta (Rhesus macaque) | SS |
Q28DL4 | traf6 | TNF receptor-associated factor 6 | Xenopus tropicalis (Western clawed frog) (Silurana tropicalis) | SS |
Q6IWL4 | traf6 | TNF receptor-associated factor 6 | Danio rerio (Zebrafish) (Brachydanio rerio) | SS |
10 | 20 | 30 | 40 | 50 | 60 |
MSLLNCENSC | GSSQSESDCC | VAMASSCSAV | TKDDSVGGTA | STGNLSSSFM | EEIQGYDVEF |
70 | 80 | 90 | 100 | 110 | 120 |
DPPLESKYEC | PICLMALREA | VQTPCGHRFC | KACIIKSIRD | AGHKCPVDNE | ILLENQLFPD |
130 | 140 | 150 | 160 | 170 | 180 |
NFAKREILSL | MVKCPNEGCL | HKMELRHLED | HQAHCEFALM | DCPQCQRPFQ | KFHINIHILK |
190 | 200 | 210 | 220 | 230 | 240 |
DCPRRQVSCD | NCAASMAFED | KEIHDQNCPL | ANVICEYCNT | ILIREQMPNH | YDLDCPTAPI |
250 | 260 | 270 | 280 | 290 | 300 |
PCTFSTFGCH | EKMQRNHLAR | HLQENTQSHM | RMLAQAVHSL | SVIPDSGYIS | EVRNFQETIH |
310 | 320 | 330 | 340 | 350 | 360 |
QLEGRLVRQD | HQIRELTAKM | ETQSMYVSEL | KRTIRTLEDK | VAEIEAQQCN | GIYIWKIGNF |
370 | 380 | 390 | 400 | 410 | 420 |
GMHLKCQEEE | KPVVIHSPGF | YTGKPGYKLC | MRLHLQLPTA | QRCANYISLF | VHTMQGEYDS |
430 | 440 | 450 | 460 | 470 | 480 |
HLPWPFQGTI | RLTILDQSEA | PVRQNHEEIM | DAKPELLAFQ | RPTIPRNPKG | FGYVTFMHLE |
490 | 500 | 510 | 520 | ||
ALRQRTFIKD | DTLLVRCEVS | TRFDMGSLRR | EGFQPRSTDA | GV |